Market revenue in 2023 | USD 485.6 million |
Market revenue in 2030 | USD 2,098.6 million |
Growth rate | 23.3% (CAGR from 2023 to 2030) |
Largest segment | Instruments |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Agilent Technologies Inc, Illumina Inc, Qiagen NV, Roche Holding AG, Macrogenics Inc, PerkinElmer, Pacific Biosciences of California Inc, BGI Group, BGC Group Inc Ordinary Shares Class A, Bio-Rad Laboratories Inc, Myriad Genetics Inc, PierianDx, Eurofins Scientific SE |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna sequencing market will help companies and investors design strategic landscapes.
Instruments was the largest segment with a revenue share of 48.81% in 2023. Horizon Databook has segmented the Japan dna sequencing market based on consumables, instruments, services covering the revenue growth of each sub-segment from 2018 to 2030.
Healthcare and clinical research service providers in Japan have been integrating Next-Generation Sequencing (NGS) technologies for the past couple of years and are expected to account for a considerable share of Asia Pacific DNA sequencing revenue share.
Ongoing developments in HLA and prenatal NGS testing coupled with international collaborations with U.S. & European companies are expected to fuel the growth of Japan DNA sequencing market during the forecast period.
Various cancer gene panels that are to be used in clinical practice have also been approved by the Ministry of Health, Labour and Welfare of Japan. However, a medical protocol for reporting and interpreting clinical variants must be developed.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan dna sequencing market , including forecasts for subscribers. This country databook contains high-level insights into Japan dna sequencing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account